Skip to main content
. Author manuscript; available in PMC: 2023 Feb 28.
Published in final edited form as: Arch Immunol Ther Exp (Warsz). 2022 Feb 28;70(1):9. doi: 10.1007/s00005-022-00648-7

Fig. 1. Mtb infection and lactoferrin treatment scheme.

Fig. 1.

C57Bl/6 mice were aerosol challenged with Mtb and treated with rHLF administered every other day orally beginning on day 14 (prophylactic relative to granulomatous responses; six total doses), or beginning on day 21 post infection (therapeutic relative to established granulomas; three total doses). Mice were intravenous injected with ofloxacin 30 min prior to sacrifice, at 28 days post initial infectious challenge.